We are live on ! Find out more
LDNAM

Lepercq De Neuflize Asset Management Portfolio holdings

AUM $138M
1-Year Est. Return 15.9%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+15.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
-$36.2M
Cap. Flow
-$35.9M
Cap. Flow %
-34.7%
Top 10 Hldgs %
99.92%
Holding
16
New
2
Increased
3
Reduced
1
Closed
2

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$23.7M
2
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$12.3M
3
LFCR icon
Lifecore Biomedical
LFCR
+$18.6K

Sector Composition

Rank Sector Weight
1 Healthcare 0.42%
2 Technology 0.12%
3 Consumer Discretionary 0.08%
4 Real Estate 0.07%
5 Energy 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$64.5M 62.41%
115,245
EFA icon
2
iShares MSCI EAFE ETF
EFA
$76.8B
$38.1M 36.87%
466,000
LFCR icon
3
Lifecore Biomedical
LFCR
$163M
$139K 0.13%
19,700
-3,000
-13% -$18.6K
XYLO
4
DELISTED
Xylo Technologies
XYLO
$128K 0.12%
26,059
WETH icon
5
Wetouch Technology
WETH
$15.5M
$98.5K 0.1%
67,954
CLAR icon
6
Clarus
CLAR
$126M
$83.3K 0.08%
22,200
+1,200
+6% +$5.38K
SQFT icon
7
Presidio Property Trust
SQFT
$3.01M
$77.1K 0.07%
13,413
ENZ
8
DELISTED
Enzo Biochem, Inc.
ENZ
$57.8K 0.06%
156,303
+33,303
+27% +$18.4K
EPIX
9
DELISTED
ESSA Pharma
EPIX
$50.1K 0.05%
31,700
+1,500
+5% +$2.54K
ANTX icon
10
AN2 Therapeutics
ANTX
$178M
$31.6K 0.03%
+23,234
New +$29.2K
LVTX
11
DELISTED
LAVA Therapeutics
LVTX
$29.2K 0.03%
+23,000
New +$25.6K
BRN icon
12
Barnwell Industries
BRN
$14.7M
$24.3K 0.02%
15,000
DSWL icon
13
Deswell Industries
DSWL
$53.8M
$23.6K 0.02%
10,000
LGL.WS
14
DELISTED
LGL Group Inc Warrants
LGL.WS
$8.38K 0.01%
26,200
ACWI icon
15
iShares MSCI ACWI ETF
ACWI
$32.5B
-104,300
Closed -$12.3M
QQQ icon
16
Invesco QQQ Trust
QQQ
$449B
-46,278
Closed -$23.7M

Similar funds

Lepercq De Neuflize Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Lepercq De Neuflize Asset Management held 16 positions worth $103M, down 26% from $139M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lepercq De Neuflize Asset Management withdrew a net $35.9M in Q1 2025, closing 2 positions and reducing 1 holding. Its most notable exit was Invesco QQQ Trust, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 0.42% of assets, up from 0.29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Lepercq De Neuflize Asset Management opened a new position in AN2 Therapeutics worth $31.6K.

  • Lepercq De Neuflize Asset Management's largest Q1 2025 buy was AN2 Therapeutics: 23,234 shares worth $31.6K.
  • Lepercq De Neuflize Asset Management added most to Enzo Biochem, Inc. in Q1 2025, an estimated $18.4K increase.
  • Lepercq De Neuflize Asset Management's biggest Q1 2025 reduction was Lifecore Biomedical, cutting an estimated $18.6K.
  • Lepercq De Neuflize Asset Management fully exited Invesco QQQ Trust in Q1 2025, selling an estimated $23.7M.
  • Lepercq De Neuflize Asset Management's ten largest holdings make up 100% of its $103M portfolio in Q1 2025.
  • Lepercq De Neuflize Asset Management opened 2 new positions and closed 2 in Q1 2025.
  • Lepercq De Neuflize Asset Management's portfolio value fell 26% quarter-over-quarter to $103M.

Based on Lepercq De Neuflize Asset Management's 13F filing for Q1 2025, filed 13 May 2025.